| 发明名称 |
5,6-BIS (4-CHLOROPHENYL)-N-PIPERIDIN1-YL-3-(PIPERIDIN-1-YL-CARBONYL)PYRAZINE-2-CARBOXAMIDE |
| 摘要 |
<p>The present invention relates to 5,6-bis(4-chlorophenyl)-N-piperidin1-yl-3-(piperidin-1-yl-carbonyl)pyrazine-2-carboxamide, to processes for preparing this compound, to its use in the treatment of obesity, psychiatric and neurological disorders, to methods for its therapeutic use and to pharmaceutical compositions containing it. The compound is a cannabinoid receptor 1 (CB1) modulator.</p> |
| 申请公布号 |
WO2004111038(A1) |
申请公布日期 |
2004.12.23 |
| 申请号 |
WO2004SE00967 |
申请日期 |
2004.06.16 |
| 申请人 |
ASTRAZENECA AB;CHENG, LEIFENG |
发明人 |
CHENG, LEIFENG |
| 分类号 |
A61P1/00;A61P3/04;A61P5/00;A61P9/00;A61P11/00;A61P25/00;A61P37/00;C07D401/14;(IPC1-7):C07D401/14;A61K31/497 |
主分类号 |
A61P1/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
